Litcius/Paper detail

Lower Lactate Levels and Lower Intracellular pH in Patients with <i>IDH</i>-Mutant versus Wild-Type Gliomas

Katharina J. Wenger, Joachim P. Steinbach, Oliver Bähr, Ulrich Pilatus, Elke Hattingen

2020American Journal of Neuroradiology16 citationsDOIOpen Access PDF

Abstract

BACKGROUND AND PURPOSE: Preclinical evidence points toward a metabolic reprogramming in isocitrate dehydrogenase (IDH) mutated tumor cells with down-regulation of the expression of genes that encode for glycolytic metabolism. We noninvasively investigated lactate and Cr concentrations, as well as intracellular pH using 1 H/phosphorus 31 ( 31 P) MR spectroscopy in a cohort of patients with gliomas.

Topics & Concepts

Intracellular pHIsocitrate dehydrogenaseIntracellularIDH1MedicineGliomaIn vivo magnetic resonance spectroscopyMutantNuclear magnetic resonanceNuclear medicineChemistryMolecular biologyBiochemistryBiologyMagnetic resonance imagingCancer researchGeneEnzymeRadiologyPhysicsGlioma Diagnosis and TreatmentAdvanced MRI Techniques and ApplicationsMRI in cancer diagnosis
Lower Lactate Levels and Lower Intracellular pH in Patients with <i>IDH</i>-Mutant versus Wild-Type Gliomas | Litcius